Literature DB >> 33199320

Update on the diagnosis and management of early rheumatoid arthritis.

Peter C Taylor1.   

Abstract

The clinical spectrum of rheumatoid arthritis (RA) presentation is heterogeneous, with wide variation in age of onset, degree of joint involvement and severity. Delayed rheumatological referral is associated with less favourable long-term outcomes. Multidisciplinary teamwork is key to the success of a holistic approach to patient care and addressing issues that are important to the person. Pharmacological treatment of early RA aims to optimally suppress the inflammatory component of the disease with an ideal treatment target of remission. The overarching aim of management of early RA is to achieve a quality of life that permits the individual to pursue normal work, domestic and social activity. © Royal College of Physicians 2020. All rights reserved.

Entities:  

Keywords:  Rheumatoid arthritis; clinical assessment; disease-modifying anti-rheumatic drugs; methotrexate; treat-to-target

Year:  2020        PMID: 33199320      PMCID: PMC7687323          DOI: 10.7861/clinmed.2020-0727

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  14 in total

1.  2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Authors:  Daniel Aletaha; Tuhina Neogi; Alan J Silman; Julia Funovits; David T Felson; Clifton O Bingham; Neal S Birnbaum; Gerd R Burmester; Vivian P Bykerk; Marc D Cohen; Bernard Combe; Karen H Costenbader; Maxime Dougados; Paul Emery; Gianfranco Ferraccioli; Johanna M W Hazes; Kathryn Hobbs; Tom W J Huizinga; Arthur Kavanaugh; Jonathan Kay; Tore K Kvien; Timothy Laing; Philip Mease; Henri A Ménard; Larry W Moreland; Raymond L Naden; Theodore Pincus; Josef S Smolen; Ewa Stanislawska-Biernat; Deborah Symmons; Paul P Tak; Katherine S Upchurch; Jirí Vencovský; Frederick Wolfe; Gillian Hawker
Journal:  Arthritis Rheum       Date:  2010-09

Review 2.  When the first visit to the rheumatologist is established rheumatoid arthritis.

Authors:  Peter C Taylor; Shing T Law
Journal:  Best Pract Res Clin Rheumatol       Date:  2020-01-27       Impact factor: 4.098

Review 3.  The epidemiology of rheumatoid arthritis.

Authors:  S E Gabriel
Journal:  Rheum Dis Clin North Am       Date:  2001-05       Impact factor: 2.670

4.  Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial.

Authors:  J Braun; P Kästner; P Flaxenberg; J Währisch; P Hanke; W Demary; U von Hinüber; K Rockwitz; W Heitz; U Pichlmeier; C Guimbal-Schmolck; A Brandt
Journal:  Arthritis Rheum       Date:  2008-01

Review 5.  Methotrexate in rheumatoid arthritis: a quarter century of development.

Authors:  Michael E Weinblatt
Journal:  Trans Am Clin Climatol Assoc       Date:  2013

Review 6.  EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update.

Authors:  Josef S Smolen; Robert Landewé; Johannes Bijlsma; Gerd Burmester; Katerina Chatzidionysiou; Maxime Dougados; Jackie Nam; Sofia Ramiro; Marieke Voshaar; Ronald van Vollenhoven; Daniel Aletaha; Martin Aringer; Maarten Boers; Chris D Buckley; Frank Buttgereit; Vivian Bykerk; Mario Cardiel; Bernard Combe; Maurizio Cutolo; Yvonne van Eijk-Hustings; Paul Emery; Axel Finckh; Cem Gabay; Juan Gomez-Reino; Laure Gossec; Jacques-Eric Gottenberg; Johanna M W Hazes; Tom Huizinga; Meghna Jani; Dmitry Karateev; Marios Kouloumas; Tore Kvien; Zhanguo Li; Xavier Mariette; Iain McInnes; Eduardo Mysler; Peter Nash; Karel Pavelka; Gyula Poór; Christophe Richez; Piet van Riel; Andrea Rubbert-Roth; Kenneth Saag; Jose da Silva; Tanja Stamm; Tsutomu Takeuchi; René Westhovens; Maarten de Wit; Désirée van der Heijde
Journal:  Ann Rheum Dis       Date:  2017-03-06       Impact factor: 19.103

7.  Rheumatoid arthritis is getting less frequent-results of a nationwide population-based cohort study.

Authors:  Abhishek Abhishek; Michael Doherty; Chang-Fu Kuo; Christian D Mallen; Weiya Zhang; Matthew J Grainge
Journal:  Rheumatology (Oxford)       Date:  2017-05-01       Impact factor: 7.580

Review 8.  Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force.

Authors:  Josef S Smolen; Ferdinand C Breedveld; Gerd R Burmester; Vivian Bykerk; Maxime Dougados; Paul Emery; Tore K Kvien; M Victoria Navarro-Compán; Susan Oliver; Monika Schoels; Marieke Scholte-Voshaar; Tanja Stamm; Michaela Stoffer; Tsutomu Takeuchi; Daniel Aletaha; Jose Louis Andreu; Martin Aringer; Martin Bergman; Neil Betteridge; Hans Bijlsma; Harald Burkhardt; Mario Cardiel; Bernard Combe; Patrick Durez; Joao Eurico Fonseca; Alan Gibofsky; Juan J Gomez-Reino; Winfried Graninger; Pekka Hannonen; Boulos Haraoui; Marios Kouloumas; Robert Landewe; Emilio Martin-Mola; Peter Nash; Mikkel Ostergaard; Andrew Östör; Pam Richards; Tuulikki Sokka-Isler; Carter Thorne; Athanasios G Tzioufas; Ronald van Vollenhoven; Martinus de Wit; Desirée van der Heijde
Journal:  Ann Rheum Dis       Date:  2015-05-12       Impact factor: 19.103

9.  How to Get the Most from Methotrexate (MTX) Treatment for Your Rheumatoid Arthritis Patient?-MTX in the Treat-to-Target Strategy.

Authors:  Peter C Taylor; Alejandro Balsa Criado; Anne-Barbara Mongey; Jerome Avouac; Hubert Marotte; Rudiger B Mueller
Journal:  J Clin Med       Date:  2019-04-15       Impact factor: 4.241

10.  The role of ultrasound-defined tenosynovitis and synovitis in the prediction of rheumatoid arthritis development.

Authors:  Ilfita Sahbudin; Luke Pickup; Peter Nightingale; Gina Allen; Zaeem Cader; Ruchir Singh; Paola de Pablo; Christopher D Buckley; Karim Raza; Andrew Filer
Journal:  Rheumatology (Oxford)       Date:  2018-07-01       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.